RESEARCHER:
Dr. Álvaro Fernández-Vega Sanz
ACTIVO
Treatment of age-related macular degeneration of the neovascular type (DMAEh) over 2 years with a treatment and extension model (T + E) of 2 mg aflibercept injected into the eye.
Inicio / Treatment of age-related macular degeneration of the neovascular type (DMAEh) over 2 years with a treatment and extension model (T + E) of 2 mg aflibercept injected into the eye.
Dr. Álvaro Fernández-Vega Sanz
ACTIVO
Treatment of age-related macular degeneration of the neovascular type (DMAEh) over 2 years with a treatment and extension model (T + E) of 2 mg aflibercept injected into the eye.
Specialties: Cataracts Presbyopia Glaucoma Myopia